GoAI
Get started
Spok Holdings, Inc. logo

Spok Holdings, Inc.

SPOK

NASDAQHealthcareMedical - Healthcare Information Services

Open in GoAI

Previous close

$10.31

−$0.13 · -1.25%

Aug 21, 4:00 PM ET

SPOK company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

82

Deep Value

Momentum

31

Weakening

Sentiment

63

Bullish

Risk resilience

54

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
US

Market position

Day range

Current $10.31

52-week range

Current $10.31

Open
$10.47
Previous close
$10.44
Volume
304.59K
Market cap
215.34M USD
50-day average
$10.713
-3.76% below average
200-day average
$11.8904
-13.29% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
253.46M USD
P/E (TTM)
17.31×
P/B (TTM)
1.54×
P/S (TTM)
1.58×
EV / EBITDA
10.19×
Earnings yield
5.84%
Free cash flow yield
9.27%
Dividend yield
12.12%

Profitability & efficiency

Gross margin
88.14%
Operating margin
13.21%
Net margin
9.00%
Return on equity
10.85%
Return on assets
7.71%
Return on invested capital
9.14%

Financial health

Debt / equity
0.04×
Current ratio
1.18×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends89%51%13%-25%Gross margin, FY2021: 49.16%Gross margin, FY2022: 55.96%Gross margin, FY2023: 58.89%Gross margin, FY2024: 79.35%Gross margin, FY2025: 78.84%Operating margin, FY2021: -8.48%Operating margin, FY2022: 5.62%Operating margin, FY2023: 15.68%Operating margin, FY2024: 13.78%Operating margin, FY2025: 14.11%Net margin, FY2021: -15.60%Net margin, FY2022: 16.25%Net margin, FY2023: 11.27%Net margin, FY2024: 10.87%Net margin, FY2025: 11.37%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 49.16%. Gross margin FY2022 55.96%. Gross margin FY2023 58.89%. Gross margin FY2024 79.35%. Gross margin FY2025 78.84%. Operating margin FY2021 -8.48%. Operating margin FY2022 5.62%. Operating margin FY2023 15.68%. Operating margin FY2024 13.78%. Operating margin FY2025 14.11%. Net margin FY2021 -15.60%. Net margin FY2022 16.25%. Net margin FY2023 11.27%. Net margin FY2024 10.87%. Net margin FY2025 11.37%.

Income trends

Revenue

139.71M USD+1.49%

Operating income

19.71M USD+3.93%

Net income

15.88M USD+6.12%
Income trends across reported periods158.59M USD92.85M USD27.12M USD−38.61M USDRevenue, FY2021: 142.15M USDRevenue, FY2022: 134.53M USDRevenue, FY2023: 139.03M USDRevenue, FY2024: 137.65M USDRevenue, FY2025: 139.71M USDOperating income, FY2021: −12.06M USDOperating income, FY2022: 7.57M USDOperating income, FY2023: 21.8M USDOperating income, FY2024: 18.97M USDOperating income, FY2025: 19.71M USDNet income, FY2021: −22.18M USDNet income, FY2022: 21.86M USDNet income, FY2023: 15.67M USDNet income, FY2024: 14.97M USDNet income, FY2025: 15.88M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 142.15M USD. Revenue FY2022 134.53M USD. Revenue FY2023 139.03M USD. Revenue FY2024 137.65M USD. Revenue FY2025 139.71M USD. Operating income FY2021 −12.06M USD. Operating income FY2022 7.57M USD. Operating income FY2023 21.8M USD. Operating income FY2024 18.97M USD. Operating income FY2025 19.71M USD. Net income FY2021 −22.18M USD. Net income FY2022 21.86M USD. Net income FY2023 15.67M USD. Net income FY2024 14.97M USD. Net income FY2025 15.88M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue139.71M USD137.65M USD139.03M USD134.53M USD142.15M USD
Cost of goods sold29.57M USD28.43M USD57.16M USD59.25M USD72.27M USD
Gross profit110.14M USD109.22M USD81.87M USD75.28M USD69.89M USD
Research and development12.09M USD11.55M USD10.55M USD13.63M USD17.92M USD
Selling, general, and administrative50.87M USD49.15M USD49.52M USD54.09M USD64.02M USD
Operating expenses90.43M USD90.26M USD60.07M USD67.72M USD81.94M USD
Interest income820K USD1.15M USD1.1M USD592K USD320K USD
Depreciation and amortization3.43M USD4.15M USD4.5M USD3.57M USD10.45M USD
Operating income19.71M USD18.97M USD21.8M USD7.57M USD−12.06M USD
Net income15.88M USD14.97M USD15.67M USD21.86M USD−22.18M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$15.00

45.49% upside
Past 12 months12-month forecastHigh $15.00Average $15.00Low $15.00

SPOK news

businesswire.com

Spok-Powered Hospitals Recognized on 2026-2027 U.S. News & World Report's Best Hospitals Honor Roll

PLANO, Texas--(BUSINESS WIRE)--Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK) and a global leader in healthcare communications, today reported that 18 of the 20 adult hospitals featured on…

Read source
marketbeat.com

Spok Q2 Earnings Call Highlights

Spok NASDAQ: SPOK reported second-quarter 2026 results marked by higher software bookings, record adjusted EBITDA and continued capital returns to stockholders, while management modestly lowered its full-year revenue…

Read source
seekingalpha.com

Spok Holdings, Inc. (SPOK) Q2 2026 Earnings Call Transcript

Spok Holdings, Inc. (SPOK) Q2 2026 Earnings Call Transcript

Read source
zacks.com

Spok Holdings (SPOK) Q2 Earnings and Revenues Surpass Estimates

Spok Holdings (SPOK) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.15 per share. This compares to earnings of $0.22 per share a year ago.

Read source
businesswire.com

Spok Reports Second Quarter 2026 Results

PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced results for the second quarter ended June 30, 2026. In addition, the Company's Board of…

Read source
businesswire.com

Spok Announces Sale of Spectrum Licenses to Sensus

PLANO, Texas--(BUSINESS WIRE)--Spok Holdings, Inc. (NASDAQ: SPOK), a global leader in healthcare communications, today announced the entry into an agreement to sell certain narrowband spectrum licenses in its two-way…

Read source

SPOK peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding SPOK

Funds reporting this stock among their holdings, ordered by reported position size.

Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
6.7M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
5.2M
Weight
0.01%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
2.59M
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
iShares Russell 2000 Value ETF logoiShares Russell 2000 Value ETFIWN
Market value
2.24M
Weight
0.02%
AUM
14.66B USD
Expense ratio
0.24%
Price / 1D
$224.81+0.45%
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
1.29M
Weight
0.01%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$121.25+0.74%
WisdomTree U.S. SmallCap Dividend Fund logoWisdomTree U.S. SmallCap Dividend FundDES
Market value
1.28M
Weight
0.06%
AUM
2.24B USD
Expense ratio
0.38%
Price / 1D
$40.83+0.39%
First Trust Dow Jones Select MicroCap Index Fund logoFirst Trust Dow Jones Select MicroCap Index FundFDM
Market value
1.18M
Weight
0.28%
AUM
423.22M USD
Expense ratio
0.65%
Price / 1D
$92.96+0.50%
Dimensional - US Targeted Value ETF logoDimensional - US Targeted Value ETFDFAT
Market value
872.96K
Weight
0.01%
AUM
14.66B USD
Expense ratio
0.28%
Price / 1D
$71.67+0.67%

Continue in GoAI

Research SPOK

research.disclaimer